Pharmaceutical companies issued two more recalls for blood pressure medications on Friday because of potential cancer-causing impurities, making it four recalls in one week. They are part of an ongoing string of recalls that started in July 2018.
Torrent Pharmaceuticals Limited recalled 60 lots of Losartan potassium tablets USP and 54 lots of Losartan potassium/hydrochlorothiazide tablets due to the detection of trace amounts of N-Methylnitrosobutyric acid (NMBA). Torrent said it was only recalling those lots in which NMBA was above the acceptable daily intake levels released by the FDA.
Read more from WFAA…
grapevinesource.com 